XML 34 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statement of Changes in Equity - USD ($)
$ in Millions
Total
Total
Common Shares
Common Stock and Capital Surplus
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance, shares at Dec. 31, 2022     85,204,006      
Beginning balance at Dec. 31, 2022   $ 4,052   $ 1,453 $ 3,142 $ (543)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings $ 852 852     852  
Other comprehensive income   224       224
Dividends (687) (687)     (687)  
Shares issued:            
Exercise of stock options, shares     96,953      
Exercise of stock options   4   4    
Restricted stock awards, shares     165,513      
Other benefit plans   13   13    
Other benefit plans, shares     104,207      
Dividend reinvestment plan, shares     20,614      
Dividend reinvestment plan   3   3    
Stock-based compensation expense   18   18    
Shares acquired and retired, shares     (1,872,544)      
Shares acquired and retired   (213)   (34) (179)  
Shares exchanged — benefit plans, shares     (64,060)      
Shares exchanged — benefit plans   (8)   (1) (7)  
Forfeitures of restricted stock, shares     (18,882)      
Ending balance, shares at Dec. 31, 2023     83,635,807      
Ending balance at Dec. 31, 2023   4,258   1,456 3,121 (319)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings 887 887     887  
Other comprehensive income   79       79
Dividends $ (791) (791)     (791)  
Shares issued:            
Exercise of stock options, shares     127,719      
Exercise of stock options   6   6    
Restricted stock awards, shares     157,681      
Other benefit plans   13   13    
Other benefit plans, shares     100,716      
Dividend reinvestment plan, shares     22,740      
Dividend reinvestment plan   3   3    
Stock-based compensation expense   18   18    
Shares exchanged — benefit plans, shares     (53,573)      
Shares exchanged — benefit plans   (7)   (1) (6)  
Forfeitures of restricted stock, shares     (12,832)      
Ending balance, shares at Dec. 31, 2024 83,978,258   83,978,258      
Ending balance at Dec. 31, 2024   4,466   1,495 3,211 (240)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings $ 842 842     842  
Other comprehensive income   190       190
Dividends $ (608) (608)     (608)  
Shares issued:            
Exercise of stock options, shares     18,932      
Exercise of stock options   1   1    
Restricted stock awards, shares     166,297      
Other benefit plans   13   13    
Other benefit plans, shares     105,123      
Dividend reinvestment plan, shares     17,932      
Dividend reinvestment plan   2   2    
Stock-based compensation expense   18   18    
Shares acquired and retired, shares     (799,398)      
Shares acquired and retired   (99)   (15) (84)  
Shares exchanged — benefit plans, shares     (43,505)      
Shares exchanged — benefit plans   (5)   (1) (4)  
Forfeitures of restricted stock, shares     (21,437)      
Ending balance, shares at Dec. 31, 2025 83,422,202   83,422,202      
Ending balance at Dec. 31, 2025   $ 4,820   $ 1,513 $ 3,357 $ (50)